A young woman presented to our hospital with a one-month history of recurrent cough. She denied having a fever recently, but her cough had gradually worsened, progressing from a dry cough to one productive of light yellow sputum. She worked as an elementary school administrative staff member. She had not traveled abroad within the past month. Apart from her child having had a common cold during the previous two weeks, there was no significant contact history or history of cluster exposure.
At her initial outpatient visit, she was diagnosed with community-acquired pneumonia and was prescribed empiric therapy with amoxicillin/clavulanate and a short-acting bronchodilator. Three days later, she returned to the clinic with worsening cough, accompanied by chest pain and shortness of breath; therefore, hospitalization was recommended.
After admission, physical examination revealed mild wheezing on auscultation, while chest radiography showed no obvious consolidation. In addition to the original amoxicillin/clavulanate therapy, a macrolide antibiotic was added, and inhaled bronchodilator therapy was initiated.
The following day, she reported symptomatic improvement. Follow-up serologic testing confirmed Mycoplasma infection. She was advised to complete the full course of macrolide therapy, and a bronchial provocation test was arranged to evaluate the possibility of asthma.
On the third hospital day, because her condition had improved markedly, she was discharged after providing an adequate sputum specimen, with follow-up arranged in the outpatient clinic.
At her initial outpatient visit, she was diagnosed with community-acquired pneumonia and was prescribed empiric therapy with amoxicillin/clavulanate and a short-acting bronchodilator. Three days later, she returned to the clinic with worsening cough, accompanied by chest pain and shortness of breath; therefore, hospitalization was recommended.
After admission, physical examination revealed mild wheezing on auscultation, while chest radiography showed no obvious consolidation. In addition to the original amoxicillin/clavulanate therapy, a macrolide antibiotic was added, and inhaled bronchodilator therapy was initiated.
The following day, she reported symptomatic improvement. Follow-up serologic testing confirmed Mycoplasma infection. She was advised to complete the full course of macrolide therapy, and a bronchial provocation test was arranged to evaluate the possibility of asthma.
On the third hospital day, because her condition had improved markedly, she was discharged after providing an adequate sputum specimen, with follow-up arranged in the outpatient clinic.
Mycoplasma pneumoniae infection commonly presents as pharyngitis, bronchitis, or wheezing. Approximately 10% of infected individuals may develop pneumonia. The onset of illness is typically gradual, evolving over several days, although a more abrupt presentation may occasionally occur. Although Mycoplasma pneumoniae pneumonia may initially manifest with a sore throat, cough is the most common presenting symptom. The cough is typically nonproductive, although some patients may have associated sputum production.
On physical examination, approximately 80% of patients exhibit wheezing or crackles on auscultation. Nevertheless, pneumonia is more commonly diagnosed radiographically. The most frequent radiographic findings include peribronchial pneumonia, bronchial wall thickening, and interstitial infiltrates. Pleural effusion is clinically observed in approximately 20% of patients.
臨床表現常無法區分黴漿菌肺炎與其他類型的社區性肺炎。當社區性肺炎對青黴素或頭孢類抗生素無效時，應考慮黴漿菌感染的可能性。儘管黴漿菌肺炎通常是自限性，但適當的抗菌治療可顯著縮短持續時間。一些患者在急性肺炎治癒後，可能伴隨長期反覆喘息。慢性感染可能與氣喘有關，需要積極追蹤複查。
The clinical manifestations of Mycoplasma pneumoniae pneumonia are often indistinguishable from those of other types of community-acquired pneumonia. M. pneumoniae infection should be considered when patients with community-acquired pneumonia fail to respond to penicillins or cephalosporins. Although M. pneumoniae pneumonia is generally a self-limiting disease, appropriate antimicrobial therapy can significantly shorten the duration of illness. Some patients may experience persistent or recurrent wheezing even after resolution of the acute pneumonia. Chronic infection has been implicated in the pathogenesis of asthma; therefore, close follow-up and further evaluation are warranted.
